Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor patch to the page. There are no changes to study content or functionality reflected in this update.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site's revision tag updated from v3.6.3 to v3.6.4. This appears to reflect an underlying software or template update, not changes to the displayed study content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a new software build. This change does not modify the study details or visible content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s deployment label was updated to include Revision: v3.6.2, while the previous label Revision: v3.6.0 was removed, indicating an updated build/version for the site.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays that recruitment has ended with 'No longer looking for participants.' New sections 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and 'Intervention/Treatment' were added, and the heading 'Intervention / Treatment' was removed along with the older 'Revision: v3.5.5' note.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This reflects a maintenance or formatting update rather than any substantive changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.